These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34252290)

  • 1. Novel Peptide NT/K-CRS Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    J Ocul Pharmacol Ther; 2021 Sep; 37(7):412-420. PubMed ID: 34252290
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
    Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
    Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
    [No Abstract]   [Full Text] [Related]  

  • 3. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
    Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
    Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
    Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X
    Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.
    Palmer GM; Tiran Z; Zhou Z; Capozzi ME; Park W; Coletta C; Pyriochou A; Kliger Y; Levy O; Borukhov I; Dewhirst MW; Rotman G; Penn JS; Papapetropoulos A
    Br J Pharmacol; 2012 Mar; 165(6):1891-1903. PubMed ID: 21943108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
    Wang Z; Zhao H; Ma JX; Xu X
    Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
    Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
    Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.
    Zhang D; Kaufman PL; Gao G; Saunders RA; Ma JX
    Diabetologia; 2001 Jun; 44(6):757-65. PubMed ID: 11440369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel and effective human hepatocyte growth factor kringle 1 domain inhibits ocular neovascularization.
    Lu Q; Zhang L; Shen X; Zhu Y; Zhang Q; Zhou Q; Gan R; Zhang H; Zhong Y; Xie B
    Exp Eye Res; 2012 Dec; 105():15-20. PubMed ID: 23085338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
    Lin W; Tu H; Zhu Y; Guan Y; Liu H; Ling W; Yan P; Dong J
    Phytomedicine; 2019 Nov; 64():152923. PubMed ID: 31450226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
    Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
    Sun Y; Su L; Wang Z; Xu Y; Xu X
    BMC Cell Biol; 2013 Feb; 14():8. PubMed ID: 23433118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
    Li YJ; Li XH; Wang LF; Kuang X; Hang ZX; Deng Y; Du JR
    Exp Eye Res; 2014 Dec; 129():119-26. PubMed ID: 25446322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel peptide derived from IGF-2 displays anti-angiogenic activity in vitro and inhibits retinal angiogenesis in a model of oxygen-induced retinopathy.
    Zheng Y; Sun Q; Xu X; Wang W
    Clin Exp Ophthalmol; 2020 Dec; 48(9):1261-1275. PubMed ID: 33026147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
    Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
    Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.
    Dal Monte M; Rezzola S; Cammalleri M; Belleri M; Locri F; Morbidelli L; Corsini M; Paganini G; Semeraro F; Cancarini A; Rusciano D; Presta M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2392-407. PubMed ID: 25766585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.